These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 33018482)
1. Misfolded protein propagation in an integrated computational model of structural network and LRRK2 gene expression. Yan W; Ye C; Wang T; Sun J; Wu T; Ma T Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():2368-2371. PubMed ID: 33018482 [TBL] [Abstract][Full Text] [Related]
2. Pathological Functions of LRRK2 in Parkinson's Disease. Jeong GR; Lee BD Cells; 2020 Nov; 9(12):. PubMed ID: 33266247 [TBL] [Abstract][Full Text] [Related]
3. LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons. Henderson MX; Peng C; Trojanowski JQ; Lee VMY Acta Neuropathol Commun; 2018 May; 6(1):45. PubMed ID: 29855356 [TBL] [Abstract][Full Text] [Related]
4. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease. Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063 [TBL] [Abstract][Full Text] [Related]
5. The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases. Tsafaras G; Baekelandt V Neurobiol Dis; 2022 Oct; 172():105806. PubMed ID: 35781002 [TBL] [Abstract][Full Text] [Related]
6. CADPS2 gene expression is oppositely regulated by LRRK2 and alpha-synuclein. Obergasteiger J; Überbacher C; Pramstaller PP; Hicks AA; Corti C; Volta M Biochem Biophys Res Commun; 2017 Aug; 490(3):876-881. PubMed ID: 28647363 [TBL] [Abstract][Full Text] [Related]
7. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487 [TBL] [Abstract][Full Text] [Related]
8. G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons. Volpicelli-Daley LA; Abdelmotilib H; Liu Z; Stoyka L; Daher JP; Milnerwood AJ; Unni VK; Hirst WD; Yue Z; Zhao HT; Fraser K; Kennedy RE; West AB J Neurosci; 2016 Jul; 36(28):7415-27. PubMed ID: 27413152 [TBL] [Abstract][Full Text] [Related]
9. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease. Daher JP Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286 [TBL] [Abstract][Full Text] [Related]
10. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons. López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501 [TBL] [Abstract][Full Text] [Related]
11. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Lin X; Parisiadou L; Gu XL; Wang L; Shim H; Sun L; Xie C; Long CX; Yang WJ; Ding J; Chen ZZ; Gallant PE; Tao-Cheng JH; Rudow G; Troncoso JC; Liu Z; Li Z; Cai H Neuron; 2009 Dec; 64(6):807-27. PubMed ID: 20064389 [TBL] [Abstract][Full Text] [Related]
12. LRRK2 kinase inhibitors reduce alpha-synuclein in human neuronal cell lines with the G2019S mutation. Zhao Y; Keshiya S; Perera G; Schramko L; Halliday GM; Dzamko N Neurobiol Dis; 2020 Oct; 144():105049. PubMed ID: 32800998 [TBL] [Abstract][Full Text] [Related]
14. Misfolded α-Synuclein Seeding Is Detected in Suspected LRRK2-Parkinson's Disease without Immunohistochemically Detectable α-Synuclein Pathology. Kim A; Martinez-Valbuena I; Keith JL; Kovacs GG; Lang AE Mov Disord; 2024 Jan; 39(1):218-220. PubMed ID: 37986700 [No Abstract] [Full Text] [Related]
15. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation. Andersen MA; Christensen KV; Badolo L; Smith GP; Jeggo R; Jensen PH; Andersen KJ; Sotty F Neurobiol Dis; 2018 Aug; 116():13-27. PubMed ID: 29680709 [TBL] [Abstract][Full Text] [Related]
16. The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation. Bae EJ; Lee SJ Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165632. PubMed ID: 31812666 [TBL] [Abstract][Full Text] [Related]
17. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo. Albanese F; Mercatelli D; Finetti L; Lamonaca G; Pizzi S; Shimshek DR; Bernacchia G; Morari M Neurobiol Dis; 2021 Nov; 159():105487. PubMed ID: 34419621 [TBL] [Abstract][Full Text] [Related]
18. Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis. Skibinski G; Hwang V; Ando DM; Daub A; Lee AK; Ravisankar A; Modan S; Finucane MM; Shaby BA; Finkbeiner S Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1165-1170. PubMed ID: 28028237 [TBL] [Abstract][Full Text] [Related]
19. Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology. Mamais A; Manzoni C; Nazish I; Arber C; Sonustun B; Wray S; Warner TT; Cookson MR; Lewis PA; Bandopadhyay R Brain Res; 2018 Dec; 1701():75-84. PubMed ID: 30055128 [TBL] [Abstract][Full Text] [Related]
20. LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation. Bae EJ; Kim DK; Kim C; Mante M; Adame A; Rockenstein E; Ulusoy A; Klinkenberg M; Jeong GR; Bae JR; Lee C; Lee HJ; Lee BD; Di Monte DA; Masliah E; Lee SJ Nat Commun; 2018 Aug; 9(1):3465. PubMed ID: 30150626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]